Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Demichelis

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
Neoplasia (New York, N.Y.)|April 3, 2007
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old modelKirsten D Mertz, Sunita R Setlur, Saravana M Dhanasekaran, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Cell Cycle (Georgetown, Tex.)|October 5, 2013
Large oncosomes mediate intercellular transfer of functional microRNAMatteo Morello, Valentina R Minciacchi, Paola de Candia, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Genome Biology|October 23, 2010
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing dataAndrea Sboner, Lukas Habegger, Dorothee Pflueger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Oncogene-mediated alterations in chromatin conformationDavid S Rickman, T David Soong, Benjamin Moss, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Cancer Research|December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progressionPei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
Neoplasia (New York, N.Y.)|April 3, 2007
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old modelKirsten D Mertz, Sunita R Setlur, Saravana M Dhanasekaran, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Cell Cycle (Georgetown, Tex.)|October 5, 2013
Large oncosomes mediate intercellular transfer of functional microRNAMatteo Morello, Valentina R Minciacchi, Paola de Candia, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Genome Biology|October 23, 2010
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing dataAndrea Sboner, Lukas Habegger, Dorothee Pflueger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Oncogene-mediated alterations in chromatin conformationDavid S Rickman, T David Soong, Benjamin Moss, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Cancer Research|December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progressionPei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Pageof 18